Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to trans... Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0711 | 56.8345323741 | 0.1251 | 0.2752 | 0.0953 | 86324548 | 0.20166736 | CS |
| 4 | -0.37 | -65.3479335924 | 0.5662 | 0.67 | 0.0953 | 26270599 | 0.20516957 | CS |
| 12 | -0.5728 | -74.4863459038 | 0.769 | 1.04 | 0.0953 | 8934924 | 0.2174682 | CS |
| 26 | -1.3338 | -87.1764705882 | 1.53 | 1.69 | 0.0953 | 4008265 | 0.25280507 | CS |
| 52 | -3.7038 | -94.9692307692 | 3.9 | 4.4599 | 0.0953 | 2213988 | 0.47569987 | CS |
| 156 | -12.9538 | -98.5079847909 | 13.15 | 13.4 | 0.0953 | 986275 | 1.60932412 | CS |
| 260 | -21.9038 | -99.1122171946 | 22.1 | 31.41 | 0.0953 | 850397 | 1.91439416 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
